A novel oral inhibitor of transglutaminase 2 appears to block gluten-induced mucosal damage in patients with celiac disease at three different doses, based on proof-of-concept
Read more
Home ยป
A novel oral inhibitor of transglutaminase 2 appears to block gluten-induced mucosal damage in patients with celiac disease at three different doses, based on proof-of-concept
Read moreThe actual causes of Irritable bowel Syndrome or IBS is as yet unclear. Some researchers speculate that the disease has roots in the central nervous
Read more